China News Service, Beijing, November 6 The reporter learned on the 6th that the artificial intelligence retinal screening system has important clinical significance and promotion and application value.
Beijing Eagle Eye Technology (Airdoc), which focuses on the field of "Medical AI-Medical Imaging AI-Retina Imaging AI", was officially listed on the main board of the Hong Kong Stock Exchange on the 5th. The net raised HK$1.5664 billion and the market capitalization exceeded HK$7 billion. Become the first medical AI company in Hong Kong stocks, committed to inclusive medical services for the health of millions of people around the world.
With the aging of the population, chronic diseases such as diabetes and hypertension have become the main health problems of Chinese residents.
With the implementation of the "Healthy China 2030" Planning Outline, the comprehensive prevention and control of chronic diseases has been upgraded to the national level.
The "Outline" proposes to reduce the premature mortality of major chronic diseases as one of the important indicators, and requires the implementation of a comprehensive prevention and control strategy for chronic diseases, and the realization of chronic disease health management for the entire population and the entire life cycle by 2030.
Artificial intelligence can effectively solve the problem of insufficient medical resources and uneven distribution, and has become an important starting point for the prevention and control of chronic diseases.
As the first medical AI stock, Airdoc is officially listed on the main board of the Hong Kong Stock Exchange. Photo by Wu Wen
According to Frost & Sullivan data, China's artificial intelligence medical imaging industry is expected to increase from 300 million yuan in 2020 to 92.3 billion yuan in 2030, with a compound annual growth rate of 76.7% from 2020 to 2030.
Specifically, the market size of artificial intelligence retinal medical imaging will increase from 76 million yuan in 2020 to 34.01 billion yuan in 2030, and the compound annual growth rate from 2020 to 2030 will exceed 80%.
At the listing ceremony, Dalei Zhang, founder of Eagle Eye Technology, and user representatives sounded the listing gong.
Lin Jianhua, Deputy District Mayor of Haidian District, Beijing, said that as the first medical AI company, he hopes that it will use this successful listing as a new starting point and opportunity to accelerate innovation, continuously enhance its core competitiveness, and repay the society and the majority of investments with better performance. By.
Zhang Hongjiang, academician of the American Institute of Electrical and Electronics Engineers (IEEE) and the International Computer Society (ACM), and chairman of the Beijing Zhiyuan Artificial Intelligence Research Institute, believes that retinal image analysis is one of the most challenging types of medical image analysis because of its pathological changes. Problems such as concurrency, multiple lesions, confusion of features, and data noise are all complicated.
Using advanced artificial intelligence technology to help doctors better serve patients is a matter of great social value.
(over)